Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 12
Submit an article Journal homepage
8,189
Views
184
CrossRef citations to date
0
Altmetric
Review

Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics

Abhishek D. GargCell Death Research & Therapy (CDRT) Lab, Department of Cellular & Molecular Medicine, KU Leuven University of Leuven, Leuven, BelgiumCorrespondence[email protected] [email protected]
ORCID Iconhttp://orcid.org/0000-0002-9976-9922
ORCID Icon,
Sanket MoreCell Death Research & Therapy (CDRT) Lab, Department of Cellular & Molecular Medicine, KU Leuven University of Leuven, Leuven, Belgium
,
Nicole RufoCell Death Research & Therapy (CDRT) Lab, Department of Cellular & Molecular Medicine, KU Leuven University of Leuven, Leuven, Belgium
,
Odeta MeceCell Death Research & Therapy (CDRT) Lab, Department of Cellular & Molecular Medicine, KU Leuven University of Leuven, Leuven, BelgiumORCID Iconhttp://orcid.org/0000-0001-6817-9383
ORCID Icon,
Maria Livia SassanoCell Death Research & Therapy (CDRT) Lab, Department of Cellular & Molecular Medicine, KU Leuven University of Leuven, Leuven, Belgium
,
Patrizia AgostinisCell Death Research & Therapy (CDRT) Lab, Department of Cellular & Molecular Medicine, KU Leuven University of Leuven, Leuven, Belgium
,
Laurence ZitvogelGustave Roussy Comprehensive Cancer Institute, Villejuif, France;INSERM, Villejuif, France;Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France;Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France
,
Guido KroemerUniversité Paris Descartes/Paris V, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;INSERM, Paris, France;Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France;Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden;Pôle de Biologie, Hopitâl Européen George Pompidou, Paris, France
&
Lorenzo GalluzziUniversité Paris Descartes/Paris V, Paris, France;Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA;Sandra and Edward Meyer Cancer Center, New York, NY, USACorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-2257-8500
ORCID Icon show all
Article: e1386829 | Received 26 Sep 2017, Accepted 26 Sep 2017, Published online: 26 Oct 2017

Citations (184)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (22)

Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, Jannes Govaerts, Stefan Naulaerts, Daniel M. Borras, Lisa Kinget, Jitka Fucíková, Radek Špíšek, Lenka Palová Jelínková, Oliver Kepp, Guido Kroemer, Dmitri V. Krysko, An Coosemans, Rianne D.W. Vaes, Dirk De Ruysscher, Steven De Vleeschouwer, Els Wauters, Evelien Smits, Sabine Tejpar, Benoit Beuselinck, Sigrid Hatse, Hans Wildiers, Paul M. Clement, Peter Vandenabeele, Laurence Zitvogel & Abhishek D. Garg. (2023) Trial watch: chemotherapy-induced immunogenic cell death in oncology. OncoImmunology 12:1.
Read now
Xiaoding Tan, Peng Fang, Kaiying Li, Meng You, Yuxia Cao, Hui Xu, Xiaohong Zhu, Lu Wang, Xin Wei, Haiying Wen, Wendi Li, Lei Shi, Xiaowei Sun, Dongan Yu, Huikai Zhu, Zhenzhen Wang, Datao Liu, Hui Shen, Wei Zhou & Maomao An. (2023) A HER2-targeted antibody-novel DNA topoisomerase I inhibitor conjugate induces durable adaptive antitumor immunity by activating dendritic cells. mAbs 15:1.
Read now
Yinjie Fan, Hang Xue & Huachuan Zheng. (2022) Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook. Journal of Hepatocellular Carcinoma 9, pages 233-263.
Read now
Alfonso Serrano Del Valle, Manuel Beltrán-Visiedo, Victoria de Poo-Rodríguez, Nelia Jiménez-Alduán, Gemma Azaceta, Rosana Díez, Beatriz Martínez-Lázaro, Isabel Izquierdo, Luis Palomera, Javier Naval, Alberto Anel & Isabel Marzo. (2022) Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis. OncoImmunology 11:1.
Read now
Kenny Misael Calvillo-Rodríguez, Rodolfo Mendoza-Reveles, Luis Gómez-Morales, Ashanti Concepción Uscanga-Palomeque, Philippe Karoyan, Ana Carolina Martínez-Torres & Cristina Rodríguez-Padilla. (2022) PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells. OncoImmunology 11:1.
Read now
Siyu Wang, Yiwei Wang, Kai Jin, Bo Zhang, Shaojun Peng, Amit Kumar Nayak & Zhiqing Pang. (2022) Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics. Expert Opinion on Drug Delivery 19:8, pages 965-984.
Read now
Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, Guido Kroemer & Jonathan G. Pol. (2021) Trial watch: intratumoral immunotherapy. OncoImmunology 10:1.
Read now
Xiaodan Qin, William D. Denton, Leah N. Huiting, Kaylee S. Smith & Hui Feng. (2020) Unraveling the regulatory role of endoplasmic-reticulum-associated degradation in tumor immunity. Critical Reviews in Biochemistry and Molecular Biology 55:4, pages 322-353.
Read now
Takahiro Yamazaki, Aitziber Buqué, Tyler D. Ames & Lorenzo Galluzzi. (2020) PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models. OncoImmunology 9:1.
Read now
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now
Sarah Lévesque, Julie Le Naour, Federico Pietrocola, Juliette Paillet, Margerie Kremer, Francesca Castoldi, Elisa E. Baracco, Yan Wang, Erika Vacchelli, Gautier Stoll, Ariane Jolly, Pierre De La Grange, Laurence Zitvogel, Guido Kroemer & Jonathan G. Pol. (2019) A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice. OncoImmunology 8:11.
Read now
Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now
Oliver Kepp, Allan Sauvat, Marion Leduc, Sabrina Forveille, Peng Liu, Liwei Zhao, Lucillia Bezu, Wei Xie, Laurence Zitvogel & Guido Kroemer. (2019) A fluorescent biosensor-based platform for the discovery of immunogenic cancer cell death inducers. OncoImmunology 8:8.
Read now
Sarah Lévesque, Jonathan G. Pol, Gladys Ferrere, Lorenzo Galluzzi, Laurence Zitvogel & Guido Kroemer. (2019) Trial watch: dietary interventions for cancer therapy. OncoImmunology 8:7.
Read now
Maria Eugenia Davola & Karen Louise Mossman. (2019) Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?. OncoImmunology 8:6.
Read now
Fengfei Sun, Lijuan Cui, Tingting Li, Silin Chen, Junmei Song & Dezhi Li. (2019) Oxaliplatin induces immunogenic cells death and enhances therapeutic efficacy of checkpoint inhibitor in a model of murine lung carcinoma. Journal of Receptors and Signal Transduction 39:3, pages 208-214.
Read now
Kristina Iribarren, Aitziber Buque, Laura Mondragon, Wei Xie, Sarah Lévesque, Jonathan Pol, Laurence Zitvogel, Oliver Kepp & Guido Kroemer. (2019) Anticancer effects of anti-CD47 immunotherapy in vivo. OncoImmunology 8:3.
Read now
Francesca Castoldi, Erika Vacchelli, Laurence Zitvogel, Maria Chiara Maiuri, Federico Pietrocola & Guido Kroemer. (2019) Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy. OncoImmunology 8:1.
Read now
Melody Smith, Elena García-Martínez, Michael R. Pitter, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Toll-like receptor agonists in cancer immunotherapy. OncoImmunology 7:12.
Read now
Lucillia Bezu, Oliver Kepp, Giulia Cerrato, Jonathan Pol, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial watch: Peptide-based vaccines in anticancer therapy. OncoImmunology 7:12.
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now
Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. OncoImmunology 7:6.
Read now

Articles from other publishers (162)

Xiaojun Huang, Qinghuan Ren, Leixiang Yang, Di Cui, Chenyang Ma, Yueliang Zheng & Junjie Wu. (2023) Immunogenic chemotherapy: great potential for improving response rates. Frontiers in Oncology 13.
Crossref
Rachel SJ Wong, Rebecca JM Ong & Joline SJ Lim. (2023) Immune checkpoint inhibitors in breast cancer: development, mechanisms of resistance and potential management strategies. Cancer Drug Resistance 6:4, pages 768-87.
Crossref
Wenxin Chou, Tianzhen Sun, Nian Peng, Zixuan Wang, Defu Chen, Haixia Qiu & Hongyou Zhao. (2023) Photodynamic Therapy-Induced Anti-Tumor Immunity: Influence Factors and Synergistic Enhancement Strategies. Pharmaceutics 15:11, pages 2617.
Crossref
Shiya Yao, Yuejun Han, Mengxiang Yang, Ketao Jin & Huanrong Lan. (2023) It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer. Frontiers in Immunology 14.
Crossref
Zhishan Xu, Mengke Xu, Xueya Wu, Sheng Guo, Zhongwei Tian, Di Zhu, Jixuan Yang, Jiyun Fu, Xi Li, Guozhen Song, Zhe Liu & Xiangfeng Song. (2023) A Half‐Sandwich Ruthenium(II) (N^N) Complex: Inducing Immunogenic Melanoma Cell Death in Vitro and in Vivo. ChemMedChem 18:16.
Crossref
Liqun Wang, Ren Luo, Kateryna Onyshchenko, Xi Rao, Meidan Wang, Beatrice Menz, Simone Gaedicke, Anca-Ligia Grosu, Elke Firat & Gabriele Niedermann. (2023) Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING. Journal for ImmunoTherapy of Cancer 11:8, pages e006235.
Crossref
Charles Dumontet, Janice M. Reichert, Peter D. Senter, John M. Lambert & Alain Beck. (2023) Antibody–drug conjugates come of age in oncology. Nature Reviews Drug Discovery 22:8, pages 641-661.
Crossref
Marzieh Nikoo, Zahraa F. Hassan, Mahsa Mardasi, Elmira Rostamnezhad, Fatemeh Roozbahani, Sahel Rahimi & Javad Mohammadi. (2023) Hepatocellular carcinoma (HCC) immunotherapy by anti-PD-1 monoclonal antibodies: A rapidly evolving strategy. Pathology - Research and Practice 247, pages 154473.
Crossref
Xiaohui Yang, Junling Yang, Xiaoxia Gu, Yuhua Tao, Hongjuan Ji, Xian Miao, Shuijie Shen & Haiyang Zang. (2022) (−)-Guaiol triggers immunogenic cell death and inhibits tumor growth in non-small cell lung cancer. Molecular and Cellular Biochemistry 478:7, pages 1611-1620.
Crossref
Jing Cui, Huizhe Xu, Ji Shi, Kun Fang, Jia Liu, Feng Liu, Yi Chen, Haiyang Liang, Ye Zhang & Haozhe Piao. (2023) Carbonic anhydrase IX inhibitor S4 triggers release of DAMPs related to immunogenic cell death in glioma cells via endoplasmic reticulum stress pathway. Cell Communication and Signaling 21:1.
Crossref
Lingpu Zhang, Nicolás Montesdeoca, Johannes Karges & Haihua Xiao. (2023) Immunogenic Cell Death Inducing Metal Complexes for Cancer Therapy. Angewandte Chemie International Edition 62:21.
Crossref
Yichao Lu & Jian You. (2023) Strategy and application of manipulating DCs chemotaxis in disease treatment and vaccine design. Biomedicine & Pharmacotherapy 161, pages 114457.
Crossref
Ranjeet Singh, Prateek Srivastava & Partha Pratim Manna. (2023) Chemokine-targeted nanoparticles: stimulation of the immune system in cancer immunotherapy. Exploration of Immunology, pages 123-147.
Crossref
Jiaqi Zhai, Xi Gu, Yang Liu, Yueting Hu, Yi Jiang & Zhenyong Zhang. (2023) Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review. Frontiers in Pharmacology 14.
Crossref
Pengzhe Han, Shaojian Mo, Zhengwang Wang, Jiale Xu, Xifeng Fu & Yanzhang Tian. (2023) UXT at the crossroads of cell death, immunity and neurodegenerative diseases. Frontiers in Oncology 13.
Crossref
Nirjari Kothari, Humzah Postwala, Aanshi Pandya, Aayushi Shah, Yesha Shah & Mehul R. Chorawala. (2023) Establishing the applicability of cancer vaccines in combination with chemotherapeutic entities: current aspect and achievable prospects. Medical Oncology 40:5.
Crossref
Lingpu Zhang, Nicolás Montesdeoca, Johannes Karges & Haihua Xiao. (2023) Immunogenen Zelltod induzierende Metallkomplexe für die Krebstherapie. Angewandte Chemie.
Crossref
Lorenzo Galluzzi, Oliver Kepp, Erik Hett, Guido Kroemer & Francesco M. Marincola. (2023) Immunogenic cell death in cancer: concept and therapeutic implications. Journal of Translational Medicine 21:1.
Crossref
Tina B.S. Miholjcic, Heloise Halse, Mélodie Bonvalet, Amélie Bigorgne, Mathieu Rouanne, Laurent Dercle, Vishnu Shankar & Aurélien Marabelle. (2023) Rationale for LDH-targeted cancer immunotherapy. European Journal of Cancer 181, pages 166-178.
Crossref
Diana Díaz-García, Sanjiv Prashar & Santiago Gómez-Ruiz. (2023) Biological Use of Nanostructured Silica-Based Materials Functionalized with Metallodrugs: The Spanish Perspective. International Journal of Molecular Sciences 24:3, pages 2332.
Crossref
Zuzana Tatarova, Dylan C. Blumberg, AeSoon Bensen, Gordon B. Mills & Oliver Jonas. (2023) Panobinostat Induced Spatial In Situ Biomarkers Predictive of Anti-PD-1 Efficacy in Mouse Mammary Carcinoma. Cells 12:2, pages 308.
Crossref
Xiaoqiong Zhang, Zhaohan Wei, Ziqiao Ding, Weilin Lv, Jianye Li, Xin Li, Haojie Liu, Panli Yu, Xiangliang Yang & Lu Gan. (2023) Boosting doxil-based chemoimmunotherapy via reprogramming tumor-associated macrophages. Chemical Engineering Journal 451, pages 138971.
Crossref
K.M. Deo & J.R. Aldrich-Wright. 2023. Comprehensive Inorganic Chemistry III. Comprehensive Inorganic Chemistry III 744 793 .
Juliette Humeau, Julie Le Naour, Guido Kroemer & Jonathan G. Pol. 2023.
Alina Serrano-Quintero, Alfonso Sequeda-Juárez, C. Angélica Pérez-Hernández, Sara M. Sosa-Delgado, Alfonso Mendez-Tenorio & Eva Ramón-Gallegos. (2022) Immunogenic analysis of epitope-based vaccine candidate induced by photodynamic therapy in MDA-MB-231 triple-negative breast cancer cells. Photodiagnosis and Photodynamic Therapy 40, pages 103174.
Crossref
Yun Zhu, Shunan Zhang, Yi Lai, Jiaxing Pan, Fangmin Chen, Tingting Wang, Fengyang Wang, Zhiai Xu, Wenjun Yang & Haijun Yu. (2022) Self‐Cooperative Prodrug Nanovesicles Migrate Immune Evasion to Potentiate Chemoradiotherapy in Head and Neck Cancer. Advanced Science 9:36.
Crossref
Kellsye P. Fabian, Joshua T. Kowalczyk, Sandy T. Reynolds & James W. Hodge. (2022) Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation. Cells 11:23, pages 3826.
Crossref
Madhu Gupta, Abhishek Wahi, Priyanka Sharma, Riya Nagpal, Neha Raina, Monika Kaurav, Jaydeep Bhattacharya, Sonia M. Rodrigues Oliveira, Karma G. Dolma, Alok K. Paul, Maria de Lourdes Pereira, Polrat Wilairatana, Mohammed Rahmatullah & Veeranoot Nissapatorn. (2022) Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects. Vaccines 10:12, pages 2011.
Crossref
Dmitri V. Krysko, Robin Demuynck, Iuliia Efimova, Faye Naessens, Olga Krysko & Elena Catanzaro. (2022) In Vitro Veritas: From 2D Cultures to Organ-on-a-Chip Models to Study Immunogenic Cell Death in the Tumor Microenvironment. Cells 11:22, pages 3705.
Crossref
Mingang He, Wenchao Gu, Yang Gao, Ying Liu, Jie Liu & Zengjun Li. (2022) Molecular subtypes and a prognostic model for hepatocellular carcinoma based on immune- and immunogenic cell death-related lncRNAs. Frontiers in Immunology 13.
Crossref
Jianzheng Wang, Shuiping Tu, Vivek P Chavda, Zhe-Sheng Chen & Xiaobing Chen. (2022) Successes and failures of immunotherapy for gastric cancer. Drug Discovery Today 27:11, pages 103343.
Crossref
Songshan Feng, Xisong Liang, Jing Li, Zeyu Wang, Hao Zhang, Ziyu Dai, Peng Luo, Zaoqu Liu, Jian Zhang, Xiaoxiong Xiao & Quan Cheng. (2022) Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM. Frontiers in Immunology 13.
Crossref
Ravindra D. Mule, Akhilesh Kumar, Shashank P. Sancheti, B. Senthilkumar, Himanshu Kumar & Nitin T. Patil. (2022) BQ-AurIPr: a redox-active anticancer Au( i ) complex that induces immunogenic cell death . Chemical Science 13:36, pages 10779-10785.
Crossref
Jiage Ding, Yanyan Zheng, Gang Wang, Junnian Zheng & Dafei Chai. (2022) The performance and perspectives of dendritic cell vaccines modified by immune checkpoint inhibitors or stimulants. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:5, pages 188763.
Crossref
Qixiong Zhang, Shanshan Li, Kun Guo, Xuemei Yin & Rongsheng Tong. (2022) Polysialylated nanoinducer for precisely enhancing apoptosis and anti-tumor immune response in B-cell lymphoma. Acta Biomaterialia 149, pages 321-333.
Crossref
Minjie Zhang, Xin Jin, Meng Gao, Yunjiao Zhang & Ben Zhong Tang. (2022) A Self‐Reporting Fluorescent Salicylaldehyde–Chlorambucil Conjugate as a Type‐II ICD Inducer for Cancer Vaccines. Advanced Materials 34:36.
Crossref
Diego de Miguel, Ariel Ramirez‐Labrada, Iratxe Uranga, Sandra Hidalgo, Llipsy Santiago, Eva María Galvez, Maykel Arias & Julián Pardo. (2021) Inflammatory cell death induced by cytotoxic lymphocytes: a dangerous but necessary liaison. The FEBS Journal 289:15, pages 4398-4415.
Crossref
Xiaoxiao Zhang, Xueying Ge, Tinghan Jiang, Ruming Yang & Sijie Li. (2022) Research progress on immunotherapy in triple‑negative breast cancer (Review). International Journal of Oncology 61:2.
Crossref
Chuizhong Fan, Cong Li, Shuang Lu, Xiaoxue Lai, Shuo Wang, Xinrong Liu, Yanzhi Song & Yihui Deng. (2022) Polysialic Acid Self-assembled Nanocomplexes for Neutrophil-Based Immunotherapy to Suppress Lung Metastasis of Breast Cancer. AAPS PharmSciTech 23:4.
Crossref
Amirhossein Mardi, Anastasia V. Shirokova, Rebar N. Mohammed, Ali Keshavarz, Angelina O. Zekiy, Lakshmi Thangavelu, Talar Ahmad Merza Mohamad, Faroogh Marofi, Navid Shomali, Amir Zamani & Morteza Akbari. (2022) Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction. Cancer Cell International 22:1.
Crossref
Cameron Vergato, Kshama A. Doshi, Darren Roblyer & David J. Waxman. (2022) Type-I Interferon Signaling Is Essential for Robust Metronomic Chemo-Immunogenic Tumor Regression in Murine Breast Cancer. Cancer Research Communications 2:4, pages 246-257.
Crossref
Aleen Khoury, Jennette A. Sakoff, Jayne Gilbert, Kieran F. Scott, Shawan Karan, Christopher P. Gordon & Janice R. Aldrich-Wright. (2022) Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity. Pharmaceutics 14:4, pages 787.
Crossref
Lvqin Fu, Xianbin Ma, Yuantong Liu, Zhigang Xu & Zhijun Sun. (2022) Applying nanotechnology to boost cancer immunotherapy by promoting immunogenic cell death. Chinese Chemical Letters 33:4, pages 1718-1728.
Crossref
Sajal Sen, Miae Won, Matthew S. Levine, Yuvin Noh, Adam C. Sedgwick, Jong Seung Kim, Jonathan L. Sessler & Jonathan F. Arambula. (2022) Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future. Chemical Society Reviews 51:4, pages 1212-1233.
Crossref
Joseph Zouein, Fady G Haddad, Roland Eid & Hampig R Kourie. (2022) The combination of immune checkpoint inhibitors and chemotherapy in advanced non-small-cell lung cancer: the rational choice. Immunotherapy 14:2, pages 155-167.
Crossref
Stefania Crucitta, Federico Cucchiara, Francesca Sciandra, Annalisa Cerbioni, Lucrezia Diodati, Concetta Rafaniello, Annalisa Capuano, Andrea Fontana, Stefano Fogli, Romano Danesi & Marzia Del Re. (2022) Pharmacological Basis of Breast Cancer Resistance to Therapies - An Overview. Anti-Cancer Agents in Medicinal Chemistry 22:4, pages 760-774.
Crossref
Huey-Jen Lin, Yingguang Liu, Denene Lofland & Jiayuh Lin. (2022) Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity. Cancers 14:2, pages 285.
Crossref
Roya Sherkat, NoushinAfshar Moghaddam, Nahid Reisi & Marzieh Rezaei. (2022) Spontaneous regression of diffuse large B-cell lymphoma in a patient with ataxia–telangiectasia. Advanced Biomedical Research 11:1, pages 31.
Crossref
Yichao Lu, Yingying Shi & Jian You. (2022) Strategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy. Journal of Controlled Release 341, pages 184-205.
Crossref
Jianjun Xu, Qichang Zheng, Xiang Cheng, Shaobo Hu, Chen Zhang, Xing Zhou, Ping Sun, Weimin Wang, Zhe Su, Tianhao Zou, Zifang Song, Yun Xia, Xiaoqing Yi & Yang Gao. (2021) Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma. Journal of Nanobiotechnology 19:1.
Crossref
Wei Jiang, Han Zhou, Qin Wang, Ziqi Chen, Wang Dong, Zixuan Guo, Yong Li, Wei Zhao, Meixiao Zhan, Yucai Wang & Ligong Lu. (2021) High drug loading and pH-responsive nanomedicines driven by dynamic boronate covalent chemistry for potent cancer immunotherapy. Nano Research 14:11, pages 3913-3920.
Crossref
Fabio Scirocchi, Chiara Napoletano, Angelica Pace, Hassan Rahimi Koshkaki, Alessandra Di Filippo, Ilaria Grazia Zizzari, Marianna Nuti & Aurelia Rughetti. (2021) Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib. Frontiers in Oncology 11.
Crossref
Yingying He, Tao Liu, Shuang Dai, Zihan Xu, Li Wang & Feng Luo. (2021) Tumor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-tumor Immunotherapy?. Frontiers in Cell and Developmental Biology 9.
Crossref
Isaac Quiros-Fernandez, Lucía Figueroa-Protti, Jorge L. Arias-Arias, Norman Brenes-Cordero, Francisco Siles, Javier Mora & Rodrigo Antonio Mora-Rodríguez. (2021) Perturbation-Based Modeling Unveils the Autophagic Modulation of Chemosensitivity and Immunogenicity in Breast Cancer Cells. Metabolites 11:9, pages 637.
Crossref
A. Skoniecka, M. Cichorek, A. Tyminska, I. Pelikant-Malecka & J. Dziewiatkowski. (2021) Melanization as unfavorable factor in amelanotic melanoma cell biology. Protoplasma 258:5, pages 935-948.
Crossref
Ye Wang, Wei Shen, Shuhan Liu, Ge Zhu, Xiandi Meng, Kuirong Mao, Jialiang Wang, Yong‐Guang Yang, Chunsheng Xiao & Tianmeng Sun. (2021) The Host‐Defense‐Peptide‐Mimicking Synthetic Polypeptides Effectively Enhance Antitumor Immunity through Promoting Immunogenic Tumor Cell Death. Macromolecular Bioscience 21:9.
Crossref
Kellsye P. Fabian, Benjamin Wolfson & James W. Hodge. (2021) From Immunogenic Cell Death to Immunogenic Modulation: Select Chemotherapy Regimens Induce a Spectrum of Immune-Enhancing Activities in the Tumor Microenvironment. Frontiers in Oncology 11.
Crossref
Alfonso Serrano-del Valle, Chantal Reina-Ortiz, Andrea Benedi, Alberto Anel, Javier Naval & Isabel Marzo. (2021) Future prospects for mitosis-targeted antitumor therapies. Biochemical Pharmacology 190, pages 114655.
Crossref
Liangtian Shao, Qing Ye & Moyang Jia. (2021) miR-130-3p Promotes MTX-Induced Immune Killing of Hepatocellular Carcinoma Cells by Targeting EPHB4. Journal of Healthcare Engineering 2021, pages 1-9.
Crossref
Claudia Tulotta, Diane V. Lefley, Charlotte K. Moore, Ana E. Amariutei, Amy R. Spicer-Hadlington, Lewis A. Quayle, Russell O. Hughes, Khawla Ahmed, Victoria Cookson, Catherine A. Evans, Jayakumar Vadakekolathu, Paul Heath, Sheila Francis, Emmanuel Pinteaux, A. Graham Pockley & Penelope D. Ottewell. (2021) IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer. npj Breast Cancer 7:1.
Crossref
Jonathan Pol. (2021) Valeur pronostique et prédictive de l’Immunoscore dans les cancers du côlon et de la vessie. Hegel N° 2:2, pages 113-118.
Crossref
Ángela-Patricia Hernández, Pablo Juanes-Velasco, Alicia Landeira-Viñuela, Halin Bareke, Enrique Montalvillo, Rafael Góngora & Manuel Fuentes. (2021) Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies. Cancers 13:11, pages 2821.
Crossref
Ann Vankerckhoven, Thaïs Baert, Matteo Riva, Christine De Bruyn, Gitte Thirion, Katja Vandenbrande, Jolien Ceusters, Ignace Vergote & An Coosemans. (2021) Type of chemotherapy has substantial effects on the immune system in ovarian cancer. Translational Oncology 14:6, pages 101076.
Crossref
Carmen Criscitiello, Chiara Corti, Gabriella Pravettoni & Giuseppe Curigliano. (2021) Managing side effects of immune checkpoint inhibitors in breast cancer. Critical Reviews in Oncology/Hematology 162, pages 103354.
Crossref
Juan Pablo Ortiz-Aguirre, Esteban Alejandro Velandia-Vargas, Oscar Mauricio Rodríguez-Bohorquez, Diego Amaya-Ramírez, David Bernal-Estévez & Carlos Alberto Parra-López. (2021) Inmunoterapia personalizada contra el cáncer basada en neoantígenos. Revisión de la literatura. Revista de la Facultad de Medicina 69:3, pages e81633.
Crossref
Francisco J Cueto, Carlos del Fresno, Paola Brandi, Alexis J. Combes, Elena Hernández-García, Alfonso R Sánchez-Paulete, Michel Enamorado, Christian P Bromley, Manuel J Gomez, Ruth Conde-Garrosa, Santos Mañes, Santiago Zelenay, Ignacio Melero, Salvador Iborra, Matthew F. Krummel & David Sancho. (2021) DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells. Journal for ImmunoTherapy of Cancer 9:5, pages e002054.
Crossref
Diwakar Bastihalli Tukaramrao, Saloni Malla, Siddharth Saraiya, Ross Allen Hanely, Aniruddha Ray, Shikha Kumari, Dayanidhi Raman & Amit K. Tiwari. (2021) A Novel Thienopyrimidine Analog, TPH104, Mediates Immunogenic Cell Death in Triple-Negative Breast Cancer Cells. Cancers 13:8, pages 1954.
Crossref
Alejandra Reyes-Ruiz, Kenny Misael Calvillo-Rodriguez, Ana Carolina Martínez-Torres & Cristina Rodríguez-Padilla. (2021) The bovine dialysable leukocyte extract IMMUNEPOTENT CRP induces immunogenic cell death in breast cancer cells leading to long-term antitumour memory. British Journal of Cancer 124:8, pages 1398-1410.
Crossref
Carine El Sissy, Amos Kirilovsky, Guy Zeitoun, Florence Marliot, Nacilla Haicheur, Christine Lagorce-Pagès, Jérôme Galon & Franck Pagès. (2021) Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer. Cancers 13:6, pages 1281.
Crossref
Erwan Eriau, Juliette Paillet, Guido Kroemer & Jonathan G. Pol. (2021) Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy. Cancers 13:6, pages 1260.
Crossref
Gonzalo R. Sequeira, Ana Sahores, Tomás Dalotto-Moreno, Ramiro M. Perrotta, Gabriela Pataccini, Silvia I. Vanzulli, María L. Polo, Derek C. Radisky, Carol A. Sartorius, Virginia Novaro, Caroline A. Lamb, Gabriel A. Rabinovich, Mariana Salatino & Claudia Lanari. (2021) Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity. Cancer Research 81:5, pages 1375-1387.
Crossref
Alberto Mantovani, Federica Marchesi, Sebastien Jaillon, Cecilia Garlanda & Paola Allavena. (2021) Tumor-associated myeloid cells: diversity and therapeutic targeting. Cellular & Molecular Immunology 18:3, pages 566-578.
Crossref
Yajie Sun, Xiangru Feng, Chao Wan, Jonathan F. Lovell, Honglin Jin & Jianxun Ding. (2021) Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy. Asian Journal of Pharmaceutical Sciences 16:2, pages 129-132.
Crossref
Julia M. DeRogatis, Karla M. Viramontes, Emily N. Neubert & Roberto Tinoco. (2021) PSGL-1 Immune Checkpoint Inhibition for CD4+ T Cell Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Lili Wang, Ruilin Guan, Lina Xie, Xinxing Liao, Kai Xiong, Thomas W. Rees, Yu Chen, Liangnian Ji & Hui Chao. (2021) An ER‐Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non‐Small‐Cell Lung Cancer. Angewandte Chemie International Edition 60:9, pages 4657-4665.
Crossref
Lili Wang, Ruilin Guan, Lina Xie, Xinxing Liao, Kai Xiong, Thomas W. Rees, Yu Chen, Liangnian Ji & Hui Chao. (2021) An ER‐Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non‐Small‐Cell Lung Cancer. Angewandte Chemie 133:9, pages 4707-4715.
Crossref
Tianyu Tang, Xing Huang, Gang Zhang, Zhengtao Hong, Xueli Bai & Tingbo Liang. (2021) Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduction and Targeted Therapy 6:1.
Crossref
Min Zhang, Zan Dai, Shevanuja Theivendran, Zhengying Gu, Liang Zhao, Hao Song, Yannan Yang & Chengzhong Yu. (2021) Nanotechnology enabled reactive species regulation in biosystems for boosting cancer immunotherapy. Nano Today 36, pages 101035.
Crossref
Clementina Sansone, Antonino Bruno, Concetta Piscitelli, Denisa Baci, Angelo Fontana, Christophe Brunet, Douglas M. Noonan & Adriana Albini. (2021) Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy. Cells 10:2, pages 231.
Crossref
Xi Zhang, Tianhui He, Yuan Li, Ling Chen, Hongyu Liu, Yu Wu & Hongyan Guo. (2021) Dendritic Cell Vaccines in Ovarian Cancer. Frontiers in Immunology 11.
Crossref
Zhiying Huang & Haifeng Hu. (2021) Arginine Deiminase Induces Immunogenic Cell Death and Is Enhanced by N-acetylcysteine in Murine MC38 Colorectal Cancer Cells and MDA-MB-231 Human Breast Cancer Cells In Vitro. Molecules 26:2, pages 511.
Crossref
Parul Agarwal, Dung T. Le & Patrick M. Boland. 2021. Novel Approaches to Colorectal Cancer. Novel Approaches to Colorectal Cancer 137 196 .
K. Hayashi, F. Nikolos, Y. C. Lee, A. Jain, E. Tsouko, H. Gao, A. Kasabyan, H. E. Leung, A. Osipov, S. Y. Jung, A. V. Kurtova & K. S. Chan. (2020) Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death. Nature Communications 11:1.
Crossref
Mi Jian, Li Ren, Guodong He, Qi Lin, Wentao Tang, Yijiao Chen, Jingwen Chen, Tianyu Liu, Meiling Ji, Ye Wei, Wenju Chang & Jianmin Xu. (2020) A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases. Journal of Translational Medicine 18:1.
Crossref
Xinxin Song, Zhuan Zhou, Hongchun Li, Yifan Xue, Xinghua Lu, Ivet Bahar, Oliver Kepp, Mien-Chie Hung, Guido Kroemer & Yong Wan. (2020) Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers. Cancer Discovery 10:12, pages 1872-1893.
Crossref
Hanzhang Zhu, Yuqiang Shan, Ke Ge, Jun Lu, Wencheng Kong & Changku Jia. (2020) Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy. Cellular Oncology 43:6, pages 1203-1214.
Crossref
Xing Huang, Tianyu Tang, Gang Zhang, Zhengtao Hong, Jian Xu, Dipesh Kumar Yadav, Xueli Bai & Tingbo Liang. (2020) Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy. npj Precision Oncology 4:1.
Crossref
Hiroyuki Arai, Yi Xiao, Fotios Loupakis, Natsuko Kawanishi, Jingyuan Wang, Francesca Battaglin, Shivani Soni, Wu Zhang, Christoph Mancao, Bodour Salhia, Shannon M Mumenthaler, Daniel J Weisenberger, Gangning Liang, Chiara Cremolini, Alfredo Falcone, Joshua Millstein & Heinz-Josef Lenz. (2020) Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer. Journal for ImmunoTherapy of Cancer 8:2, pages e001714.
Crossref
Beatrice Casadei, Lisa Argnani, Alice Morigi, Ginevra Lolli, Alessandro Broccoli, Cinzia Pellegrini, Laura Nanni, Vittorio Stefoni, Paolo E. Coppola, Matteo Carella, Michele Cavo & Pier Luigi Zinzani. (2020) Effectiveness of chemotherapy after anti‐PD‐1 blockade failure for relapsed and refractory Hodgkin lymphoma. Cancer Medicine 9:21, pages 7830-7836.
Crossref
Reham Ajina, David J. Zahavi, Yong-Wei Zhang & Louis M. Weiner. (2020) Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodies. Seminars in Cancer Biology 65, pages 28-37.
Crossref
Mariana M.S. Oliveira & Lisa S. Westerberg. (2020) Cytoskeletal regulation of dendritic cells: An intricate balance between migration and presentation for tumor therapy. Journal of Leukocyte Biology 108:4, pages 1051-1065.
Crossref
Lei Zhou, Pengcheng Zhang, Hao Wang, Dangge Wang & Yaping Li. (2020) Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy. Accounts of Chemical Research 53:9, pages 1761-1772.
Crossref
Anjali Lathwal, Rajesh Kumar & Gajendra P.S. Raghava. (2020) OvirusTdb: A database of oncolytic viruses for the advancement of therapeutics in cancer. Virology 548, pages 109-116.
Crossref
F. Pagès, T. André, J. Taieb, D. Vernerey, J. Henriques, C. Borg, F. Marliot, R. Ben Jannet, C. Louvet, L. Mineur, J. Bennouna, J. Desrame, R. Faroux, A. Kirilovsky, A. Duval, P. Laurent-Puig, M. Svrcek, F. Hermitte, A. Catteau, J. Galon & J.-F. Emile. (2020) Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study. Annals of Oncology 31:7, pages 921-929.
Crossref
Ahmed E. M. Elhassanny, Eman Soliman, Mona Marie, Paul McGuire, Waseem Gul, Mahmoud ElSohly & Rukiyah Van Dross. (2020) Heme-Dependent ER Stress Apoptosis: A Mechanism for the Selective Toxicity of the Dihydroartemisinin, NSC735847, in Colorectal Cancer Cells. Frontiers in Oncology 10.
Crossref
Alfonso Serrano-del Valle, Javier Naval, Alberto Anel & Isabel Marzo. (2020) Novel Forms of Immunomodulation for Cancer Therapy. Trends in Cancer 6:6, pages 518-532.
Crossref
Aleen Khoury, Krishant M. Deo & Janice R. Aldrich-Wright. (2020) Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action. Journal of Inorganic Biochemistry 207, pages 111070.
Crossref
Juliette Humeau, Allan Sauvat, Giulia Cerrato, Wei Xie, Friedemann Loos, Francesca Iannantuoni, Lucillia Bezu, Sarah Lévesque, Juliette Paillet, Jonathan Pol, Marion Leduc, Laurence Zitvogel, Hugues de Thé, Oliver Kepp & Guido Kroemer. (2020) Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress. EMBO Molecular Medicine 12:5.
Crossref
Kevin Matha, Giovanna Lollo, Giuseppe Taurino, Renaud Respaud, Ilaria Marigo, Molood Shariati, Ovidio Bussolati, An Vermeulen, Katrien Remaut & Jean-Pierre Benoit. (2020) Bioinspired hyaluronic acid and polyarginine nanoparticles for DACHPt delivery. European Journal of Pharmaceutics and Biopharmaceutics 150, pages 1-13.
Crossref
Wujun Chen, Shuai Wang, Yudong Wu, Xin Shen, Zhu Guo, Qian Li & Dongming Xing. (2020) Immunogenic cell death: A link between gut microbiota and anticancer effects. Microbial Pathogenesis 141, pages 103983.
Crossref
Paride Papadia, Katia Micoli, Alessandra Barbanente, Nicoletta Ditaranto, James D. Hoeschele, Giovanni Natile, Cristina Marzano, Valentina Gandin & Nicola Margiotta. (2020) Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance. International Journal of Molecular Sciences 21:7, pages 2325.
Crossref
Yan Wang, Wei Xie, Juliette Humeau, Guo Chen, Peng Liu, Jonathan Pol, Zhen Zhang, Oliver Kepp & Guido Kroemer. (2020) Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy. Journal for ImmunoTherapy of Cancer 8:1, pages e000462.
Crossref
Bin Du & David J. Waxman. (2020) Medium dose intermittent cyclophosphamide induces immunogenic cell death and cancer cell autonomous type I interferon production in glioma models. Cancer Letters 470, pages 170-180.
Crossref
Jan Dörrie, Niels Schaft, Gerold Schuler & Beatrice Schuler-Thurner. (2020) Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update. Pharmaceutics 12:2, pages 92.
Crossref
Maria Angela Aznar, Carmen Molina, Alvaro Teijeira, Inmaculada Rodriguez, Arantza Azpilikueta, Saray Garasa, Alfonso R Sanchez‐Paulete, Luna Cordeiro, Iñaki Etxeberria, Maite Alvarez, Sergio Rius‐Rocabert, Estanislao Nistal‐Villan, Pedro Berraondo & Ignacio Melero. (2019) Repurposing the yellow fever vaccine for intratumoral immunotherapy. EMBO Molecular Medicine 12:1.
Crossref
Jian Ye, Bradley N. Mills, Tony Zhao, Booyeon J. Han, Joseph D. Murphy, Ankit P. Patel, Carl J. Johnston, Edith M. Lord, Brian A. Belt, David C. Linehan & Scott A. Gerber. (2020) Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer. Cancer Immunology Research 8:1, pages 94-107.
Crossref
Anita Sveen, Scott Kopetz & Ragnhild A. Lothe. (2019) Biomarker-guided therapy for colorectal cancer: strength in complexity. Nature Reviews Clinical Oncology 17:1, pages 11-32.
Crossref
Shentong Fang, Patrizia Agostinis, Petri Salven & Abhishek D. Garg. 2020. Tumor Immunology and Immunotherapy – Integrated Methods Part B. Tumor Immunology and Immunotherapy – Integrated Methods Part B 185 207 .
Jenny Sprooten & Abhishek D. Garg. 2020. Biology of the Endoplasmic Reticulum. Biology of the Endoplasmic Reticulum 63 118 .
Takahiro Yamazaki, Aitziber Buqué, Marissa Rybstein, Jonathan Chen, Ai Sato & Lorenzo Galluzzi. 2020. Biomarkers for Immunotherapy of Cancer. Biomarkers for Immunotherapy of Cancer 433 452 .
M. Angela Aznar, Lourdes Planelles, Mercedes Perez-Olivares, Carmen Molina, Saray Garasa, Iñaki Etxeberría, Guiomar Perez, Inmaculada Rodriguez, Elixabet Bolaños, Pedro Lopez-Casas, Maria E. Rodriguez-Ruiz, Jose L. Perez-Gracia, Ivan Marquez-Rodas, Alvaro Teijeira, Marisol Quintero & Ignacio Melero. (2019) Immunotherapeutic effects of intratumoral nanoplexed poly I:C. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Yanke Zhang, Sufen Yang, Yang Yang & Teng Liu. (2019) Resveratrol induces immunogenic cell death of human and murine ovarian carcinoma cells. Infectious Agents and Cancer 14:1.
Crossref
Constantin N. Baxevanis, Sotirios P. Fortis & Sonia A. Perez. (2019) The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies. Seminars in Cancer Biology.
Crossref
Claire Donohoe, Mathias O. Senge, Luís G. Arnaut & Lígia C. Gomes-da-Silva. (2019) Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1872:2, pages 188308.
Crossref
Krishant M. Deo, Jennette Sakoff, Jayne Gilbert, Yingjie Zhang & Janice R. Aldrich Wright. (2019) Synthesis, characterisation and influence of lipophilicity on cellular accumulation and cytotoxicity of unconventional platinum( iv ) prodrugs as potent anticancer agents . Dalton Transactions 48:46, pages 17228-17240.
Crossref
Shubhankar Nath, Girgis Obaid & Tayyaba Hasan. (2019) The Course of Immune Stimulation by Photodynamic Therapy: Bridging Fundamentals of Photochemically Induced Immunogenic Cell Death to the Enrichment of T‐Cell Repertoire. Photochemistry and Photobiology 95:6, pages 1288-1305.
Crossref
Caterina Lapenta, Simona Donati, Francesca Spadaro, Laura Lattanzi, Francesca Urbani, Iole Macchia, Paola Sestili, Massimo Spada, Maria Christina Cox, Filippo Belardelli & Stefano M. Santini. (2019) Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine. Cancer Immunology, Immunotherapy 68:11, pages 1791-1804.
Crossref
Olivier Demaria, Stéphanie Cornen, Marc Daëron, Yannis Morel, Ruslan Medzhitov & Eric Vivier. (2019) Harnessing innate immunity in cancer therapy. Nature 574:7776, pages 45-56.
Crossref
Cameron Louttit, Kyung Soo Park & James J. Moon. (2019) Bioinspired nucleic acid structures for immune modulation. Biomaterials 217, pages 119287.
Crossref
Ronald Anderson, Annette J. Theron & Bernardo L. Rapoport. (2019) Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells. Frontiers in Immunology 10.
Crossref
Jesús García-Foncillas, Yu Sunakawa, Dan Aderka, Zev Wainberg, Philippe Ronga, Pauline Witzler & Sebastian Stintzing. (2019) Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors. Frontiers in Oncology 9.
Crossref
Kent T. J. Chen, Roger Gilabert-Oriol, Marcel B. Bally & Ada W. Y. Leung. (2019) Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia. Pharmaceutical Research 36:9.
Crossref
Horrevorts, Stolk, Ven, Hulst, Hof, Duinkerken, Heineke, Ma, Dusoswa, Nieuwland, Garcia-Vallejo, Loosdrecht, de Gruijl, Vliet & van Kooyk. (2019) Glycan-Modified Melanoma-Derived Apoptotic Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination. Cancers 11:9, pages 1266.
Crossref
Bastien Doix, Natalia Trempolec, Olivier Riant & Olivier Feron. (2019) Low Photosensitizer Dose and Early Radiotherapy Enhance Antitumor Immune Response of Photodynamic Therapy-Based Dendritic Cell Vaccination. Frontiers in Oncology 9.
Crossref
Kazuki Tatsuno, Takahiro Yamazaki, Douglas Hanlon, Patrick Han, Eve Robinson, Olga Sobolev, Alp Yurter, Felix Rivera-Molina, Najla Arshad, Richard L. Edelson & Lorenzo Galluzzi. (2019) Extracorporeal photochemotherapy induces bona fide immunogenic cell death. Cell Death & Disease 10:8.
Crossref
Ilio Vitale, Gwenola Manic, Claudia Galassi & Lorenzo Galluzzi. (2019) Stress responses in stromal cells and tumor homeostasis. Pharmacology & Therapeutics 200, pages 55-68.
Crossref
Sylvia Adams, Margaret E. Gatti-Mays, Kevin Kalinsky, Larissa A. Korde, Elad Sharon, Laleh Amiri-Kordestani, Harry Bear, Heather L. McArthur, Elizabeth Frank, Jane Perlmutter, David B. Page, Benjamin Vincent, Jennifer F. Hayes, James L. Gulley, Jennifer K. Litton, Gabriel N. Hortobagyi, Stephen Chia, Ian Krop, Julia White, Joseph Sparano, Mary L. Disis & Elizabeth A. Mittendorf. (2019) Current Landscape of Immunotherapy in Breast Cancer. JAMA Oncology 5:8, pages 1205.
Crossref
Wei Li, Jie Yang, Lihua Luo, Mengshi Jiang, Bing Qin, Hang Yin, Chunqi Zhu, Xiaoling Yuan, Junlei Zhang, Zhenyu Luo, Yongzhong Du, Qingpo Li, Yan Lou, Yunqing Qiu & Jian You. (2019) Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death. Nature Communications 10:1.
Crossref
Xiaoguang Li, Zhida Liu, Anli Zhang, Chuanhui Han, Aijun Shen, Lingxiang Jiang, David A. Boothman, Jian Qiao, Yang Wang, Xiumei Huang & Yang-Xin Fu. (2019) NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance. Nature Communications 10:1.
Crossref
Paola Giglio, Mara Gagliardi, Roberta Bernardini, Maurizio Mattei, Diego Cotella, Claudio Santoro, Mauro Piacentini & Marco Corazzari. (2018) Ecto-Calreticulin is essential for an efficient immunogenic cell death stimulation in mouse melanoma. Genes & Immunity 20:6, pages 509-513.
Crossref
Ilio Vitale, Antonella Sistigu, Gwenola Manic, Nils-Petter Rudqvist, Zlatko Trajanoski & Lorenzo Galluzzi. (2019) Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy. Trends in Cell Biology 29:5, pages 396-416.
Crossref
Alfonso Serrano-del Valle, Alberto Anel, Javier Naval & Isabel Marzo. (2019) Immunogenic Cell Death and Immunotherapy of Multiple Myeloma. Frontiers in Cell and Developmental Biology 7.
Crossref
Eric Assenat, Georges-Philippe Pageaux, Simon Thézenas, Jean-Marie Peron, Yves Bécouarn, Jean-François Seitz, Philippe Merle, Jean-Frédéric Blanc, Olivier Bouché, Mohamed Ramdani, Sylvain Poujol, Hélène de Forges, Marc Ychou & Valérie Boige. (2019) Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial. British Journal of Cancer 120:9, pages 896-902.
Crossref
Joost Hof, Klaas Kok, Rolf H. Sijmons & Koert P. de Jong. (2019) Systematic Review of the Prognostic Role of the Immune System After Surgery of Colorectal Liver Metastases. Frontiers in Oncology 9.
Crossref
María E. Rodríguez-Ruiz, Inmaculada Rodríguez, Lina Mayorga, Tania Labiano, Benigno Barbes, Iñaki Etxeberria, Mariano Ponz-Sarvise, Arantza Azpilikueta, Elixabet Bolaños, Miguel F. Sanmamed, Pedro Berraondo, Felipe A. Calvo, Mary Helen Barcelos-Hoff, Jose L. Perez-Gracia & Ignacio Melero. (2019) TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies. Molecular Cancer Therapeutics 18:3, pages 621-631.
Crossref
Vidula V. Sukhatme, Suresh S. Ramalingam, Rafi Ahmed & Vikas P. Sukhatme. (2019) Repurposing Food and Drug Administration–Approved Drugs to Promote Antitumor Immunity. The Cancer Journal 25:2, pages 88-99.
Crossref
Bernardo Rapoport & Ronald Anderson. (2019) Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy. International Journal of Molecular Sciences 20:4, pages 959.
Crossref
Bernhard Englinger, Christine Pirker, Petra Heffeter, Alessio Terenzi, Christian R. Kowol, Bernhard K. Keppler & Walter Berger. (2018) Metal Drugs and the Anticancer Immune Response. Chemical Reviews 119:2, pages 1519-1624.
Crossref
Reece G. Kenny & Celine J. Marmion. (2019) Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?. Chemical Reviews 119:2, pages 1058-1137.
Crossref
Jian Gao, Fusheng Deng & Weidong Jia. (2019) Inhibition of Indoleamine 2,3-Dioxygenase Enhances the Therapeutic Efficacy of Immunogenic Chemotherapeutics in Breast Cancer. Journal of Breast Cancer 22:2, pages 196.
Crossref
Ashanti Concepción Uscanga‐Palomeque, Kenny Misael Calvillo‐Rodríguez, Luis Gómez‐Morales, Eva Lardé, Thomas Denèfle, Diana Caballero‐Hernández, Hélène Merle‐Béral, Santos A. Susin, Philippe Karoyan, Ana Carolina Martínez‐Torres & Cristina Rodríguez‐Padilla. (2018) CD 47 agonist peptide PKHB 1 induces immunogenic cell death in T‐cell acute lymphoblastic leukemia cells . Cancer Science 110:1, pages 256-268.
Crossref
Jianzhong Qin, Nicholas M. Kunda, Guilin Qiao, Kiara Tulla, Bellur S. Prabhakar & Ajay V. Maker. (2019) Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases. Journal of Surgical Research 233, pages 57-64.
Crossref
Patrick Han, Douglas Hanlon, Olga Sobolev, Rabib Chaudhury & Richard L. Edelson. 2019. Immunobiology of Dendritic Cells Part B. Immunobiology of Dendritic Cells Part B 251 307 .
Sreekumar Balan, Mansi Saxena & Nina Bhardwaj. 2019. Immunobiology of Dendritic Cells Part A. Immunobiology of Dendritic Cells Part A 1 68 .
Jenny Sprooten, Patrizia Agostinis & Abhishek D. Garg. 2019. Immunobiology of Dendritic Cells Part A. Immunobiology of Dendritic Cells Part A 217 262 .
Claire Lhuillier & Lorenzo Galluzzi. 2019. Immunobiology of Dendritic Cells Part B. Immunobiology of Dendritic Cells Part B xi xvi .
Claire Lhuillier & Lorenzo Galluzzi. 2019. Immunobiology of Dendritic Cells Part A. Immunobiology of Dendritic Cells Part A ix xiv .
Russell J. Needham & Peter J. Sadler. 2019. The Periodic Table II. The Periodic Table II 175 201 .
Shang-Jui Wang & Bruce Haffty. (2018) Radiotherapy as a New Player in Immuno-Oncology. Cancers 10:12, pages 515.
Crossref
Emanuela Felley-Bosco. (2018) Special Issue on Mechanisms of Mesothelioma Heterogeneity: Highlights and Open Questions. International Journal of Molecular Sciences 19:11, pages 3560.
Crossref
Lien Lybaert, Karim Vermaelen, Bruno G. De Geest & Lutz Nuhn. (2018) Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity. Journal of Controlled Release 289, pages 125-145.
Crossref
Maiko Matsushita & Mai Kawaguchi. (2018) Immunomodulatory Effects of Drugs for Effective Cancer Immunotherapy. Journal of Oncology 2018, pages 1-7.
Crossref
Zeiyad Alkarakooly, Qudes A. Al-Anbaky, Krishnaswamy Kannan & Nawab Ali. (2018) Metabolic reprogramming by Dichloroacetic acid potentiates photodynamic therapy of human breast adenocarcinoma MCF-7 cells. PLOS ONE 13:10, pages e0206182.
Crossref
Akio Osa, Takeshi Uenami, Shohei Koyama, Kosuke Fujimoto, Daisuke Okuzaki, Takayuki Takimoto, Haruhiko Hirata, Yukihiro Yano, Soichiro Yokota, Yuhei Kinehara, Yujiro Naito, Tomoyuki Otsuka, Masaki Kanazu, Muneyoshi Kuroyama, Masanari Hamaguchi, Taro Koba, Yu Futami, Mikako Ishijima, Yasuhiko Suga, Yuki Akazawa, Hirotomo Machiyama, Kota Iwahori, Hyota Takamatsu, Izumi Nagatomo, Yoshito Takeda, Hiroshi Kida, Esra A. Akbay, Peter S. Hammerman, Kwok-kin Wong, Glenn Dranoff, Masahide Mori, Takashi Kijima & Atsushi Kumanogoh. (2018) Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients. JCI Insight 3:19.
Crossref
Martin Dalziel, Stephen A Beers, Mark S Cragg & Max Crispin. (2018) Through the barricades: overcoming the barriers to effective antibody-based cancer therapeutics. Glycobiology 28:9, pages 697-712.
Crossref
A. I. Zinchenko, A. S. Schokolova & L. L. Birichevskaya. (2018) ON THE PROBLEM OF DEVELOPMENT OF THE UNIVERSAL IMMUNOTHERAPEUTIC ANTICANCER VACCINE. Proceedings of the National Academy of Sciences of Belarus, Biological Series 63:3, pages 374-381.
Crossref
Cédric Rossi, Julia Gilhodes, Marie Maerevoet, Charles Herbaux, Franck Morschhauser, Pauline Brice, Sylvain Garciaz, Cécile Borel, Loïc Ysebaert, Lucie Obéric, Julien Lazarovici, Bénédicte Deau, Jehan Dupuis, Adrien Chauchet, Julie Abraham, Fontanet Bijou, Aspasia Stamatoullas-Bastard, Jean-Valère Malfuson, Camille Golfier, Camille Laurent, Sarah Pericart, Alexandra Traverse-Glehen, Salim Kanoun, Thomas Filleron, René-Olivier Casasnovas & Hervé Ghesquières. (2018) Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers. American Journal of Hematology 93:8, pages 1042-1049.
Crossref
Erminia Romano, Nicole Rufo, Hannelie Korf, Chantal Mathieu, Abhishek D. Garg & Patrizia Agostinis. (2018) BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells. Oncotarget 9:25, pages 17631-17644.
Crossref
Maarten Versteven, Johan M. J. Van den Bergh, Elly Marcq, Evelien L. J. Smits, Viggo F. I. Van Tendeloo, Willemijn Hobo & Eva Lion. (2018) Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer. Frontiers in Immunology 9.
Crossref
Shetal A. Patel & Andy J. Minn. (2018) Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies. Immunity 48:3, pages 417-433.
Crossref
Alsya J. Affandi, Tiago Carvalheiro, Timothy R.D.J. Radstake & Wioleta Marut. (2018) Dendritic cells in systemic sclerosis: Advances from human and mice studies. Immunology Letters 195, pages 18-29.
Crossref
Carlos Rosales. (2018) Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?. Frontiers in Physiology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.